OrbiMed Israel BioFund GP Limited Partnership 13D and 13G filings for INNOVATE BIOPHARMACEUTICALS IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-01 5:20 pm Sale |
2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% |
-3,027,545 (-19.68%) |
Filing |
| 2021-06-28 5:24 pm Sale |
2021-06-24 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6.000% |
-17,118,837 (-52.67%) |
Filing |
| 2021-04-07 4:46 pm Unchanged |
2021-04-05 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.200% |
0 (Unchanged) |
Filing |
| 2021-03-25 5:26 pm Unchanged |
2021-03-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.600% |
0 (Unchanged) |
Filing |
| 2020-12-16 5:13 pm Purchase |
2020-12-15 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16.000% |
1,943,734 (+6.36%) |
Filing |
| 2020-07-29 1:38 pm Unchanged |
2020-07-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 21.400% |
0 (Unchanged) |
Filing |
| 2020-05-14 5:25 pm Purchase |
2020-05-04 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 27.300% |
30,559,521 (New Position) |
Filing |